UY27576A1 - SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH - Google Patents

SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

Info

Publication number
UY27576A1
UY27576A1 UY27576A UY27576A UY27576A1 UY 27576 A1 UY27576 A1 UY 27576A1 UY 27576 A UY27576 A UY 27576A UY 27576 A UY27576 A UY 27576A UY 27576 A1 UY27576 A1 UY 27576A1
Authority
UY
Uruguay
Prior art keywords
small molecules
treatment
cell growth
abnormal cell
erbb2
Prior art date
Application number
UY27576A
Other languages
Spanish (es)
Inventor
James D Moyer
John C Kath
Richard D Connell
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to UY27576A priority Critical patent/UY27576A1/en
Publication of UY27576A1 publication Critical patent/UY27576A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a moléculas pequenas que son útiles en el tratamiento del crecimiento celular anormal, tal como el cáncer, en mamíferos. Esta invención también se refiere a un procedimiento de uso de tales moléculas pequenas en el tratamiento del crecimiento celular anormal en mamíferos, especialmente en seres humanos, y a composiciones farmacéuticas que contienen tales compuestos. La invención se refiere además a pequenas moléculas que son selectivas para el receptor erbB2 respecto al receptor erbB1, teniendo dicho inhibidor de erbB2 un intervalo de selectividades por erbB2 respecto a erbB1 entre 50-1500.This invention relates to small molecules that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such small molecules in the treatment of abnormal cell growth in mammals, especially in humans, and to pharmaceutical compositions containing such compounds. The invention further relates to small molecules that are selective for the erbB2 receptor with respect to the erbB1 receptor, said erbB2 inhibitor having a range of selectivities for erbB2 with respect to erbB1 between 50-1500.

UY27576A 2002-12-10 2002-12-10 SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH UY27576A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27576A UY27576A1 (en) 2002-12-10 2002-12-10 SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27576A UY27576A1 (en) 2002-12-10 2002-12-10 SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

Publications (1)

Publication Number Publication Date
UY27576A1 true UY27576A1 (en) 2003-07-31

Family

ID=38812722

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27576A UY27576A1 (en) 2002-12-10 2002-12-10 SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

Country Status (1)

Country Link
UY (1) UY27576A1 (en)

Similar Documents

Publication Publication Date Title
ECSP045146A (en) SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
ECSP066406A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
HN2005000212A (en) PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
PA8680701A1 (en) OXINDOL DERIVATIVES
PA8468401A1 (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
GT200600517A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
NI200900190A (en) SULFONIL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH. PC33495A
PA8643201A1 (en) AMINOHETEROARILO COMPOUNDS REPLACED WITH PIRAZOL AS PROTEIN QUINASE INHIBITORS
UY28894A1 (en) PIRIMIDINE DERIVATIVES TO TREAT ANOMAL CELL GROWTH
CO6341574A2 (en) COMPOSITIONS OF DL PD-1 ANTAGONISTS AND METHODS OF USE
CL2007002492A1 (en) Compounds derived from bi-, tri or non-aromatic polycycles, inhibitors of the 11-beta-hydroxysteroid dehydrogenase enzyme type i; process of preparation of these; pharmaceutical composition that includes them; use in the treatment of diseases such as obesity, diabetes and dyslipidemia, among others.
UY28731A1 (en) CHEMICAL COMPOUNDS
CO6331473A2 (en) DERIVATIVES OF 2,3-DIHYDROBENZO [1,4] DIOXIN-2-ILMETILO AS ALFA2C ANTAGONISTS FOR USE IN THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISEASES
CL2008000202A1 (en) Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain.
PA8577201A1 (en) 3-PHENYL-PROPIONAMIDE, 3-PHENYL-ACRYLAMID AND DERIVATIVES 3-PHENYL-PROPINAMID AS MAO-B INHIBITORS
ECSP066925A (en) DERIVATIVES OF PIPERIDINE AS ANTAGONISTS OF THE CHEMIOKIN RECEPTOR
HN2003000080A (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS AND PROCEDURES FOR USE
UY30706A1 (en) DIARIL, DIPIRIDINIL AND ARILPIRIDINIL DERIVATIVES AND USES OF THE SAME
AR056279A1 (en) DERIVATIVES OF ARIL 1,4- PIRAZINA SUBSTITUTED, PHARMACEUTICAL COMPOSITION AND AN IN VITRO METHOD
CR7989A (en) 7-ALQUINILAMINO- TRIAZOLOPIRIMIDINAS, PROCEDURES FOR ITS OBTAINING AND THE USE OF THE SAME TO CONTROL HARMFUL FUNGES, AS WELL AS PRODUCTS THAT CONTAIN IT
AR072425A1 (en) USE OF NIFURTIMOX FOR THE TREATMENT OF GIARDIASIS
PE20061042A1 (en) DERIVATIVES OF 5-PHENYLPYRIMIDINE AS AGENTS FOR THE TREATMENT OF CANCER
AR026209A1 (en) BASIC MONOCICLIC COMPOUNDS WITH NK-2 ACTION ANTAGONIST, MANUFACTURING PROCESSES AND FORMULAS CONTAINING THEM
UY27576A1 (en) SMALL MOLECULES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
UY28136A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126